Pharmaceutical Manufacturing; Pharmacy Issues; Clinical Pharm-Assist; Medicare Prescription Drug Benefits; American's Health Choices Act (HR 3200), Regulations under MMA re: Medicare Prescription Drug Benefits; Amendments to the Social Security Act Relating To Prescription Drugs.
Provisions contained in:HR 3200, America's Affordable Health Choices Act of 2009;
America's Healthy Future Act of 2009 (Senate Finance Committee' Baucus Bill Proposal)
Affordable Health Choices Act of 2009 (Senate Committee on Health, Education, Labor and Pensions Committee Proposed Legislation;
THE HEALTH CARE & EDUCATION RECONCILIATION ACT of 2010 (H.R. 4872) The Patient Protection and Affordable Care Act of 2010 (H.R.3590)
Duration: August 9, 2009
to
March 31, 2011
General Issues: Health Issues , Pharmacy , Medicare/Medicaid
Spending: about $100,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2009: House of Representatives, U.S. Senate, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2011
DUMBARTON GROUP & ASSOCIATES, LLC terminated an engagement in which they represented Strativa Pharmaceuticals on April 20, 2011.
Original Filing: 300373942.xml
4th Quarter, 2010
In Q4, DUMBARTON GROUP & ASSOCIATES, LLC lobbied for Strativa Pharmaceuticals . The report was filed on Jan. 17, 2011.
Original Filing: 300339623.xml
Lobbying Issues
Pharmaceutical Manufacturing; Pharmacy Issues; Clinical Pharm-Assist; Medicare Prescription Drug Benefits; American's Health Choices Act (HR 3200), Regulations under MMA re: Medicare Prescription Drug Benefits; Amendments to the Social Security Act Relating To Prescription Drugs.
Provisions contained in:HR 3200, America's Affordable Health Choices Act of 2009;
America's Healthy Future Act of 2009 (Senate Finance Committee' Baucus Bill Proposal)
Affordable Health Choices Act of 2009 (Senate Committee on Health, Education, Labor and Pensions Committee Proposed Legislation;
THE HEALTH CARE & EDUCATION RECONCILIATION ACT of 2010 (H.R. 4872) The Patient Protection and Affordable Care Act of 2010 (H.R.3590)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2010
In Q3, DUMBARTON GROUP & ASSOCIATES, LLC lobbied for Strativa Pharmaceuticals . The report was filed on Oct. 19, 2010.
Original Filing: 300317343.xml
Lobbying Issues
Pharmaceutical Manufacturing; Pharmacy Issues; Clinical Pharm-Assist; Medicare Prescription Drug Benefits; American's Health Choices Act (HR 3200), Regulations under MMA re: Medicare Prescription Drug Benefits; Amendments to the Social Security Act Relating To Prescription Drugs.
Provisions contained in:HR 3200, America's Affordable Health Choices Act of 2009;
America's Healthy Future Act of 2009 (Senate Finance Committee' Baucus Bill Proposal)
Affordable Health Choices Act of 2009 (Senate Committee on Health, Education, Labor and Pensions Committee Proposed Legislation;
THE HEALTH CARE & EDUCATION RECONCILIATION ACT of 2010 (H.R. 4872) The Patient Protection and Affordable Care Act of 2010 (H.R.3590)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2010
In Q2, DUMBARTON GROUP & ASSOCIATES, LLC lobbied for Strativa Pharmaceuticals . The report was filed on July 14, 2010.
Original Filing: 300286098.xml
Lobbying Issues
Pharmaceutical Manufacturing; Pharmacy Issues; Clinical Pharm-Assist; Medicare Prescription Drug Benefits; American's Health Choices Act (HR 3200), Regulations under MMA re: Medicare Prescription Drug Benefits; Amendments to the Social Security Act Relating To Prescription Drugs.
Provisions contained in:HR 3200, America's Affordable Health Choices Act of 2009;
America's Healthy Future Act of 2009 (Senate Finance Committee' Baucus Bill Proposal)
Affordable Health Choices Act of 2009 (Senate Committee on Health, Education, Labor and Pensions Committee Proposed Legislation;
THE HEALTH CARE & EDUCATION RECONCILIATION ACT of 2010 (H.R. 4872) The Patient Protection and Affordable Care Act of 2010 (H.R.3590)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2010
In Q1, DUMBARTON GROUP & ASSOCIATES, LLC lobbied for Strativa Pharmaceuticals , earning $20,000. The report was filed on April 19, 2010.
Original Filing: 300265070.xml
Lobbying Issues
Pharmaceutical Manufacturing; Pharmacy Issues; Clinical Pharm-Assist; Medicare Prescription Drug Benefits; American's Health Choices Act (HR 3200), Regulations under MMA re: Medicare Prescription Drug Benefits; Amendments to the Social Security Act Relating To Prescription Drugs.
Provisions contained in:HR 3200, America's Affordable Health Choices Act of 2009;
America's Healthy Future Act of 2009 (Senate Finance Committee' Baucus Bill Proposal)
Affordable Health Choices Act of 2009 (Senate Committee on Health, Education, Labor and Pensions Committee Proposed Legislation;
THE HEALTH CARE & EDUCATION RECONCILIATION ACT of 2010 (H.R. 4872) The Patient Protection and Affordable Care Act of 2010 (H.R.3590)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2009
In Q4, DUMBARTON GROUP & ASSOCIATES, LLC lobbied for Strativa Pharmaceuticals , earning $50,000. The report was filed on Jan. 19, 2010.
Original Filing: 300235484.xml
Lobbying Issues
Pharmaceutical Manufacturing; Pharmacy Issues; Clinical Pharm-Assist; Medicare Prescription Drug Benefits; American's Health Choices Act (HR 3200), Regulations under MMA re: Medicare Prescription Drug Benefits; Amendments to the Social Security Act Relating To Prescription Drugs.
Provisions contained in:HR 3200, America's Affordable Health Choices Act of 2009;
America's Healthy Future Act of 2009 (Senate Finance Committee' Baucus Bill Proposal)
Affordable Health Choices Act of 2009 (Senate Committee on Health, Education, Labor and Pensions Committee Proposed Legislation
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2009
In Q3, DUMBARTON GROUP & ASSOCIATES, LLC lobbied for Strativa Pharmaceuticals , earning $30,000. The report was filed on Oct. 20, 2009.
Original Filing: 300214471.xml
Lobbying Issues
Pharmaceutical Manufacturing; Pharmacy Issues; Clinical Pharm-Assist; Medicare Prescription Drug Benefits; American's Health Choices Act (HR 3200), Regulations under MMA re: Medicare Prescription Drug Benefits; Amendments to the Social Security Act Relating To Prescription Drugs.
Provisions contained in:HR 3200, America's Affordable Health Choices Act of 2009;
America's Healthy Future Act of 2009 (Senate Finance Committee' Baucus Bill Proposal)
Affordable Health Choices Act of 2009 (Senate Committee on Health, Education, Labor and Pensions Committee Proposed Legislation
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2009
DUMBARTON GROUP & ASSOCIATES, LLC filed a lobbying registration on Oct. 17, 2009 to represent Strativa Pharmacueticals, effective Aug. 9, 2009.
Original Filing: 300209000.xml
Issue(s) they said they’d lobby about: Pharmaceutical Manufacturing; Pharmacy Issues; Clinical Pharm-Assist; Medicare Prescription Drug Benefits; American's Health Choices Act (HR 3200), Regulations under MMA re: Medicare Prescription Drug Benefits; Amendments to the Social Security Act Relating To Prescription Drugs. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate